Clinical Trial Will Assess Immunotherapy Combo in Multiple Myeloma Patients in 2017
Adaptimmune Therapeutics and Merck have agreed to begin a clinical trial next year assess the safety and efficacy of combining the anti-PD-1 inhibitor Keytruda…
News
Multiple Myeloma Patients Treated at Higher-volume Facilities Have Better Outcomes, Study Finds
Patients treated for multiple myeloma at facilities that see a higher number of multiple myeloma patients annually had better outcomes compared to patients who were treated at…
Longer Revlimid Maintenance after Stem Cell Transplant Prolongs Myeloma Patient Survival
Longer duration of maintenance therapy with Revlimid (lenalidomide) after autologous hematopoietic stem cell transplantation (HSCT) prolongs survival for multiple myeloma patients without increasing…
Experimental Myeloma Agent Shows Promise in Combination with Immunotherapies
Inhibiting a key protein in the tumor microenvironment using Noxxon’s experimental agent NOX-A12 may enhance the clinical activity of immunotherapies that boost T-cells or natural…
Xgeva Matches Standard of Care in Delaying Bone Lesions in Multiple Myeloma Patients, Amgen Reports
Amgen announced that its RANKL inhibitor, Xgeva (denosumab) met its primary endpoint in a  Phase 3 trial as a potential treatment for bone complications in…
Darzalex Combo Therapy Shows Promise in Relapsed or Refractory Multiple Myeloma Patients
A three-drug therapy combination consisting of Darzalex (daratumumab) with Revlimid (lenalidomide) and Decadron (dexamethasone) shows real potential in increasing survival in patients with…
Multiple Myeloma Studied in New Mouse Model Developed at Yale
Understanding how multiple myeloma develops and responds to therapies may be easier using a new mouse model developed at Yale University School of Medicine. The model supports…
WT1 Vaccine Helped High-Risk Multiple Myeloma Patients After Stem Cell Transplant
High-risk multiple myeloma patients may benefit markedly from galinpepimut-S, an experimental immunotherapy from SELLAS Life Sciences, following autologous stem cell transplant (ASCT), according to recent…
UV Light Robots Reduced Hospital-Acquired Infections by 25%, Study Finds
Robots can do all sorts of tasks to improve cancer treatment and now researchers have added room cleaning to the list. Indeed, Robots that use…
FDA Grants Priority Review to Darzalex Combo Therapy for Relapsed Multiple Myeloma Patients
The U.S. Food and Drug Administration (FDA) is giving priority review to a supplemental Biologics License Application (sBLA) to approve Genmab‘s Darzalex (…
Recent Posts
- Germany clears pelareorep pancreatic cancer trial continuation
- FDA grants orphan drug status to novel brain cancer treatment
- Medicaid expansion can raise demand for gynecologic cancer care
- Under-the-skin Sarclisa found as effective as approved formulation
- FDA gives LYT-200 fast track status as potential AML treatment